Search clinical trials for: grass pollen season

Total 6076 results

University of Aarhus
Aarhus University Hospital; Innovation Fund Denmark

Recruiting

A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment

Grass Pollen Allergy | Rhinoconjunctivitis

Denmark
University of Zurich
University of Aarhus

Active, not recruiting

Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract

Allergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Allergic Asthma | Rhinitis; Allergic, With Asthma

Switzerland
Imperial College London
ALK-Abelló A/S

Completed

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Rhinitis, Allergic, Seasonal

United Kingdom
Allergy Therapeutics

Completed

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen

Seasonal Allergic Rhinitis | Rhinoconjunctivitis

United States, Germany, Austria, Hungary, Czechia, Poland
Allergy Therapeutics
Bencard Allergie GmbH

Active, not recruiting

Tyrosine Allergoid Paediatric and Adult Study

Allergic Conjunctivitis | Allergic Asthma | Allergic Rhinitis Due to Pollen

Germany
Imperial College London
Novartis Pharmaceuticals

Completed

Repeat Nasal Allergen Challenge

Hayfever

United Kingdom
Imperial College London
ALK-Abelló A/S

Completed

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

Rhinitis, Allergic, Seasonal

United Kingdom
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals; PPD; Rho Federal Systems Division, Inc.; ALK-Abelló A/S and other collaborators

Active, not recruiting

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (GRADUATE)

Grass Pollen Allergy | Allergic Rhinoconjunctivitis

United Kingdom
AOBiome LLC
Integrium; Orange County Research Center

Completed

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Allergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Healthy Volunteers

United States, Canada
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital

Completed

Intralymphatic Immunotherapy in Increasing Doses, Substudy

Rhinitis, Allergic, Seasonal

Sweden
MacroArray Diagnostics GmbH

Completed

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens (MADMAX)

Cat Allergy | Grass Pollen Allergy | Birch Pollen Allergy | House Dust Mite Allergy | Bee Venom Allergy | Vespid Venom Allergy

Austria
Medical University of Lublin

Completed

Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus

Allergic Rhinitis

Poland
Medical University of Lublin

Completed

The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells

Allergic Rhinitis Due to Grass Pollen

Poland
Inmunotek S.L.

Completed

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy (MG56)

Rhinitis | Rhinoconjunctivitis

Spain
Medical University of Vienna

Completed

Iron and Pollen Allergy in Women

Healthy | Allergy Pollen

Austria
Medical University of Lublin

Completed

Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis

Allergic Rhinitis

Poland
Bayside Health

Completed

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

Allergic Rhinitis

Australia
Labo'Life

Completed

Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen (LLB-2016-01)

Seasonal Allergy

Belgium
ASIT Biotech S.A.

Unknown

Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever

Spain, Belgium, Italy
Fraunhofer-Institute of Toxicology and Experimental...
Hannover Medical School

Completed

Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis

Atopic Dermatitis | Allergy Pollen

Germany
National Institute of Allergy and Infectious Diseases...
Imperial College London; Immune Tolerance Network (ITN)

Completed

Long-Term Effects of Sublingual Grass Therapy

Rhinitis, Allergic, Seasonal

United Kingdom
ALK-Abelló A/S

Completed

Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)

Rhinitis, Allergic, Seasonal
Fraunhofer-Institute of Toxicology and Experimental...

Completed

The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit

Asthma | Seasonal Allergic Rhinitis

Germany
Biomay AG

Completed

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Hypersensitivity

Austria
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Abbott

Completed

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinitis

Russian Federation
Biomay AG

Completed

Phase II Study of Grass Pollen Allergy Vaccine BM32

Grass Pollen Allergy

Austria, Belgium, Denmark, Germany, Netherlands, Slovenia
University of Zurich
AlleCure

Completed

A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Rhinoconjunctivitis Due to Grass Pollen Allergy

Switzerland
Johann Wolfgang Goethe University Hospital

Completed

Regulatory T-cells After Subcutaneous Immunotherapy (RTCAS)

Grass Pollen Allergy | Specific Immunotherapy

Germany
BioTech Tools S.A.

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Hay Fever

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Grass Pollen Allergy

Germany
BioTech Tools S.A.

Completed

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
BioTech Tools S.A.

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Hay Fever

Belgium
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Grass Pollen Allergy

Germany
UCB Pharma

Completed

POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

Seasonal Allergic Rhinitis
UCB Pharma

Completed

Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

Rhinitis, Allergic, Seasonal
Nestlé

Completed

Effect of a Probiotic on Seasonal Allergic Rhinitis Symptoms

Seasonal Allergic Rhinitis

Germany
Nestlé

Completed

Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals

Seasonal Allergic Rhinitis

Switzerland
University Hospitals Cleveland Medical Center

Unknown

The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions (SCIT)

Asthma | Allergic Rhinitis | Allergic Conjunctivitis

United States
University of Aarhus
Spirare ApS

Completed

Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)

Rhinitis, Allergic, Seasonal

Denmark
Biomay AG

Completed

Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy

Grass Pollen Allergy

Austria
ALK-Abelló A/S

Completed

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (GT-17)

Allergic Rhinitis | Grass Allergy

Italy
Medical University of Lodz
Allergopharma GmbH & Co. KG

Completed

Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy

Seasonal Allergic Rhinitis

Poland
HAL Allergy

Completed

PURETHAL Grasses Rush Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany
Max Zeller Soehne AG

Completed

MOA Study of Ze 339 in Seasonal Allergic Rhinitis (PETRA)

Seasonal Allergic Rhinitis

Germany
Ministry of Science and Higher Education, Poland

Completed

Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy

Seasonal Allergic Rhinitis | Immunotherapy

Poland
BioTech Tools S.A.

Completed

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium

Search clinical trials for: grass pollen season

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations